Have your own idea? Try our Stock Screener
Malaysian (KLSE) Pharma Industry Analysis
UpdatedFeb 20, 2026
DataAggregated Company Financials
Companies5
- 7D4.7%
- 3M11.5%
- 1Y13.5%
- YTD13.5%
The Pharma industry is up 4.7% in the last week, with Duopharma Biotech Berhad up 9.2%. This means that the industry has gained 14% over the past year. Earnings are forecast to grow by 10% annually.
Industry Valuation and Performance
Has the Malaysian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 20 Feb 2026 | RM 2.6b | RM 1.9b | RM 165.6m | 14.8x | 16x | 1.4x |
| Sun, 18 Jan 2026 | RM 4.3b | RM 2.8b | RM 231.9m | 14.8x | 18.5x | 1.5x |
| Tue, 16 Dec 2025 | RM 4.2b | RM 2.8b | RM 231.9m | 14.5x | 18.1x | 1.5x |
| Thu, 13 Nov 2025 | RM 4.3b | RM 2.8b | RM 223.3m | 15.8x | 19x | 1.5x |
| Sat, 11 Oct 2025 | RM 4.3b | RM 2.8b | RM 223.3m | 16.2x | 19.1x | 1.5x |
| Mon, 08 Sep 2025 | RM 4.2b | RM 2.8b | RM 223.3m | 15.8x | 18.6x | 1.5x |
| Wed, 06 Aug 2025 | RM 4.2b | RM 2.8b | RM 230.3m | 15.5x | 18x | 1.5x |
| Fri, 04 Jul 2025 | RM 4.1b | RM 2.8b | RM 230.3m | 15.8x | 18x | 1.5x |
| Sun, 01 Jun 2025 | RM 4.1b | RM 2.8b | RM 230.3m | 16.3x | 17.8x | 1.5x |
| Tue, 29 Apr 2025 | RM 3.9b | RM 2.8b | RM 221.0m | 17x | 17.7x | 1.4x |
| Thu, 27 Mar 2025 | RM 3.7b | RM 2.8b | RM 221.0m | 16.3x | 16.9x | 1.4x |
| Sat, 22 Feb 2025 | RM 4.1b | RM 2.8b | RM 229.7m | 16.6x | 17.9x | 1.5x |
| Mon, 20 Jan 2025 | RM 4.0b | RM 2.7b | RM 223.9m | 16.5x | 17.9x | 1.5x |
| Wed, 18 Dec 2024 | RM 4.2b | RM 2.7b | RM 223.9m | 16.9x | 18.7x | 1.5x |
| Fri, 15 Nov 2024 | RM 4.2b | RM 2.7b | RM 236.8m | 14x | 17.8x | 1.5x |
| Sun, 13 Oct 2024 | RM 4.5b | RM 2.7b | RM 230.0m | 14.4x | 19.4x | 1.7x |
| Tue, 10 Sep 2024 | RM 4.3b | RM 2.7b | RM 230.0m | 14.4x | 18.5x | 1.6x |
| Thu, 08 Aug 2024 | RM 4.2b | RM 2.6b | RM 541.3m | 12.6x | 7.7x | 1.6x |
| Sat, 06 Jul 2024 | RM 4.5b | RM 2.6b | RM 541.3m | 13.1x | 8.3x | 1.7x |
| Mon, 03 Jun 2024 | RM 4.5b | RM 2.6b | RM 541.4m | 13.3x | 8.3x | 1.7x |
| Wed, 01 May 2024 | RM 4.8b | RM 2.6b | RM 559.3m | 12.3x | 8.5x | 1.8x |
| Fri, 29 Mar 2024 | RM 4.5b | RM 2.6b | RM 559.3m | 12.2x | 8.1x | 1.7x |
| Sun, 25 Feb 2024 | RM 4.5b | RM 2.6b | RM 557.0m | 12.6x | 8.1x | 1.7x |
| Tue, 23 Jan 2024 | RM 4.3b | RM 2.6b | RM 584.9m | 12.3x | 7.4x | 1.7x |
| Thu, 21 Dec 2023 | RM 4.2b | RM 2.6b | RM 584.9m | 12.6x | 7.2x | 1.6x |
| Sat, 18 Nov 2023 | RM 4.2b | RM 2.6b | RM 596.8m | 12.3x | 7.1x | 1.7x |
| Mon, 16 Oct 2023 | RM 4.3b | RM 2.6b | RM 604.4m | 12.2x | 7.2x | 1.7x |
| Wed, 13 Sep 2023 | RM 4.3b | RM 2.6b | RM 604.4m | 12.3x | 7x | 1.7x |
| Fri, 11 Aug 2023 | RM 4.3b | RM 2.6b | RM 304.7m | 14.1x | 14.2x | 1.7x |
| Sun, 09 Jul 2023 | RM 4.3b | RM 2.6b | RM 304.7m | 14.2x | 14x | 1.7x |
| Tue, 06 Jun 2023 | RM 4.6b | RM 2.6b | RM 304.7m | 14.7x | 15x | 1.8x |
| Thu, 04 May 2023 | RM 4.6b | RM 2.5b | RM 289.8m | 13.6x | 16x | 1.9x |
| Sat, 01 Apr 2023 | RM 4.8b | RM 2.5b | RM 289.8m | 13.1x | 16.5x | 1.9x |
| Mon, 27 Feb 2023 | RM 4.9b | RM 2.5b | RM 288.7m | 13.2x | 16.9x | 2x |
Price to Earnings Ratio
16.9x
Current Industry PE
- Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 16.0x which is higher than its 3-year average PE of 14.2x.
- The 3-year average PS ratio of 1.6x is higher than the industry's current PS ratio of 1.4x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years,
- Revenues have also declined 9.2% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Malaysian Healthcare industry?
| MY Market | 0.44% | |
| Healthcare | 2.00% | |
| Pharma | 4.69% | |
| Pharma | 4.69% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DPHARMA Duopharma Biotech Berhad | RM 1.55 | 9.2% +RM 125.1m | 26.0% | PE17.9x | |
| RHONEMA Rhone Ma Holdings Berhad | RM 0.71 | 1.4% +RM 2.2m | 7.6% | PE11.7x | |
| PLABS PeterLabs Holdings Berhad | RM 0.27 | 1.9% +RM 1.4m | 43.2% | PE30.2x |